Our findings demonstrate that ABC transporters exhibit distinct peripheral regulatory patterns in schizophrenia, with ABCC1 and ABCB1 potentially relating to inflammatory- and pharmacodynamic variability, while ABCA2 may reflect a treatment-associated metabolic adjustment rather than a pathophysiological deficit. The gene discussed is ABCA2; the disease is schizophrenia.